KLAS Hologic Hologic Selenia Dimensions 3D Breast Tomosynthesis Best In Award

September 11, 2014 — Hologic Inc. announced that its 3-D mammography system (Hologic Selenia Dimensions 3D Breast Tomosynthesis) was named "Best in KLAS" in the digital mammography category based on the results of an annual independent survey of healthcare executives and clinicians by KLAS Research. The "2014 Best in KLAS: Medical Equipment and Infrastructure" report examined more than 100 products in 23 different medical equipment and infrastructure categories. Hologic 3-D Mammography received the highest performance rating, a 95.2 on a scale of 1 to 100, of all the products evaluated in all 23 categories. Hologic's 2-D mammography system placed second in the digital mammography category.

It is the third consecutive year that Hologic 3-D and 2-D digital mammography systems have held the first and second place rankings, and the fifth year in a row that a Hologic mammography product has held first place in the digital mammography category. Hologic's 3-D mammography system consistently outperformed the digital mammography market segment average in the five key performance measures used to evaluate systems in this category: sales and contracting; implementation and training; functionality and upgrades; service and support; and general.

Earlier this year, KLAS issued a special report, "Breast Imaging 2014: Finding a Partner for the Future." One of the focuses of the report was which mammography product, as well as which vendor, breast-imaging sites would choose if they were making the decision to purchase today. The report named Hologic the top choice for a mammography product and vendor partner because of the company's technology leadership in both 3-D and 2-D mammography. Moreover, 100 percent of the Hologic customers interviewed stated they would choose to partner with the Company again for their digital mammography needs.

Hologic 3-D mammography was the first U.S. Food and Drug Administration FDA approved 3-D mammography system in the United States. This technology was approved for breast cancer screening and diagnosis in the United States in February, 2011 and has been available in countries recognizing the CE mark since 2008. Hologic 3-D mammography technology is in use in all 50 states and more than 50 countries.

In the United States, an estimated 6 million women will be screened with the Hologic 3-D technology in 2014. Hologic has more than 1,100 3-D mammography systems installed in the U.S.

For more information: www.3Dmammography.com


Related Content

News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Mammography

Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers will introduce new capabilities for its Mammomat B.brilliant ...

Time December 02, 2025
arrow
News | RSNA 2025

Dec. 2, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, will present 14 studies at RSNA ...

Time December 02, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
News | Mammography

Nov. 26, 2025 — GE HealthCare has announced it received FDA Premarket Authorization for Pristina Recon DL, an advanced ...

Time November 29, 2025
arrow
News | Ultrasound Imaging

Nov. 12, 2025 — GE HealthCare and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their ...

Time November 20, 2025
arrow
News | Breast Imaging

Nov. 17, 2025 — RadNet, Inc. and its wholly owned subsidiary, DeepHealth have announced results from the largest real ...

Time November 17, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
Subscribe Now